Healthcare -
Biotechnology - NASDAQ - US
$ 7.2
-2.3 %
$ 6 M
Market Cap
-0.01
P/E
RNAZ - OPERATING INCOME
Operating Income RNAZ - TransCode Therapeutics, Inc.
-15.7 M
LAST VALUE
8.40%
2 YEAR CAGR
-102.77%
5 YEAR CAGR
0.00%
10 YEAR CAGR